Evidence map›Paper›PMID 32803677›Full record

ArticleEndocrine2021

Identification and analyzes of DUOX2 mutations in two familial congenital hypothyroidism cases.

Liangshan Li, Wenmiao Liu, Liqin Zhang, Fang Wang, Fengqi Wang, Maosheng Gu, Xiuli Wang, Shiguo Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Liangshan LiMedical Genetic Department, the Affiliated Hospital of Qingdao University, Qingdao, China.
Wenmiao LiuMedical Genetic Department, the Affiliated Hospital of Qingdao University, Qingdao, China.
Liqin ZhangChild Health Care Department, Qingdao Women and Children's Hospital, Qingdao, China.
Fang WangEndocrinology Department, the Affiliated Hospital of Qingdao University, Qingdao, China.
Fengqi WangMedical Genetic Department, the Affiliated Hospital of Qingdao University, Qingdao, China.
Maosheng GuCenter for Genetic Medicine, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, China.
Xiuli WangNeonatal Screening Center, Xuzhou Maternity and Child Health Care Hospital, Xuzhou, China. wxl19811228@163.com.
Shiguo LiuMedical Genetic Department, the Affiliated Hospital of Qingdao University, Qingdao, China. liushiguo2002@126.com.
Qingdao University · CNAffiliated Hospital of Qingdao University · CNMaternal and Child Health Hospital of Xuzhou · CNQingdao Women and Children's Hospital · CN

Funding

National Key Research and Development Program of China 2016YFC1000306
6 · The paper itself

Abstract

backgroundMutations in DUOX2 are the frequent cause of congenital hypothyroidism (CH), a common neonatal metabolic disorder characterized by great phenotypic variability. CH can be traditionally subclassified into two subtypes: thyroid dysgenesis (TD) and thyroid dyshormonogenesis. The objectives of this study were to analyze the genetic data of two familial CH cases, to elucidate the pathogenesis from the perspective of genetics and to review and summarize the previous findings.

methodsTargeted regions sequencing (TRS) technology covering all exons and intron-exon boundaries of 35 known and potential CH-related candidate target genes in combination with Sanger sequencing were performed to identify the likely pathogenic mutations of the six patients with familial CH.

resultsIn family 1, two DUOX2 missense mutations, namely, c.1060C>T/p.R354W in exon 10 and c.3200C>T/p.S1067L in exon 25, were found. Patient 1 (P1), P2 and P3 were transient CH (TCH) patients with eutopic thyroid glands of normal size and function. In family 2, only the mutation c.3200C>T/p.S1067L was identified. P4, P5, and P6 were diagnosed with permanent CH (PCH), which requires lifelong levothyroxine (L-T4) treatment. Furthermore, both P4 and P5 harbored properly located thyroid glands, whereas P6 had a mildly reduced gland. P1, P3, P6, and other family members carrying monoallelic or biallelic DUOX2 mutations showed no obvious abnormal clinical symptoms or signs, while P2, P4, and P5 showed umbilical hernias.

conclusionsThe present study suggests that the phenotypic features resulting from DUOX2 mutations vary greatly. The p.R354W and p.S1067L alterations or the combination of the two alterations in DUOX2 are probably only predisposing to CH and DUOX2 may be involved in the morphogenesis of the human thyroid gland. Simultaneously, the compensation of DUOX1 for the loss of DUOX2, undetectable pathogenic mutations, the effects of environmental factors, epigenetic mechanisms and the involvement of multiple genes cannot be excluded in the explanation of these genetic results.

Indexed as

Congenital HypothyroidismDual OxidasesThyroid DysgenesisHumansInfant, NewbornMutationNADPH OxidasesDual OxidasesDUOX2 protein, humanNADPH OxidasesCongenital hypothyroidism (CH)Molecular analysesPredisposing variantsSanger sequencingTargeted region sequencing (TRS)Thyroid gland

Identifiers

PMID32803677
OpenAlexW3049739282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.